These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 1518749)

  • 1. Anticoagulant therapy for atrial fibrillation. Recommendations from major studies.
    Kahn JK
    Postgrad Med; 1992 Sep; 92(3):119-24, 129-30. PubMed ID: 1518749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventing stroke in patients with nonrheumatic atrial fibrillation.
    Nelson KM; Talbert RL
    Am J Hosp Pharm; 1994 May; 51(9):1175-83. PubMed ID: 8042636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Atrial fibrillation and thromboembolic events prevention. State of the art].
    Matteoli S; Trappolini M; Chillotti FM
    Minerva Cardioangiol; 2001 Feb; 49(1):1-13. PubMed ID: 11279381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Status of antithrombotic therapy for patients with atrial fibrillation in university hospitals.
    Albers GW; Yim JM; Belew KM; Bittar N; Hattemer CR; Phillips BG; Kemp S; Hall EA; Morton DJ; Vlasses PH
    Arch Intern Med; 1996 Nov; 156(20):2311-6. PubMed ID: 8911237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stroke Prevention in Atrial Fibrillation Study. Final results.
    Circulation; 1991 Aug; 84(2):527-39. PubMed ID: 1860198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombotic therapy in atrial fibrillation.
    Turpie AG; Connolly SJ
    Can Fam Physician; 1996 Jul; 42():1341-5. PubMed ID: 8754703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter.
    Cairns JA; Connolly S; McMurtry S; Stephenson M; Talajic M;
    Can J Cardiol; 2011; 27(1):74-90. PubMed ID: 21329865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis.
    Hart RG; Benavente O; McBride R; Pearce LA
    Ann Intern Med; 1999 Oct; 131(7):492-501. PubMed ID: 10507957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indications for anticoagulation in atrial fibrillation.
    Akhtar W; Reeves WC; Movahed A
    Am Fam Physician; 1998 Jul; 58(1):130-6. PubMed ID: 9672433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics and management of acute stroke in patients with atrial fibrillation admitted to US university hospitals.
    Albers GW; Bittar N; Young L; Hattemer CR; Gandhi AJ; Kemp SM; Hall EA; Morton DJ; Yim J; Vlasses PH
    Neurology; 1997 Jun; 48(6):1598-604. PubMed ID: 9191773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?
    Go AS; Hylek EM; Chang Y; Phillips KA; Henault LE; Capra AM; Jensvold NG; Selby JV; Singer DE
    JAMA; 2003 Nov; 290(20):2685-92. PubMed ID: 14645310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Atrial fibrillation: anticoagulants or not?].
    Zimmermann M
    Schweiz Med Wochenschr; 1994 Sep; 124(35):1560-5. PubMed ID: 7939523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study.
    Lancet; 1994 Mar; 343(8899):687-91. PubMed ID: 7907677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of warfarin and aspirin for prophylaxis of stroke in patients with nonvalvular atrial fibrillation.
    Gage BF; Cardinalli AB; Albers GW; Owens DK
    JAMA; 1995 Dec; 274(23):1839-45. PubMed ID: 7500532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary report of the Stroke Prevention in Atrial Fibrillation Study.
    Stroke Prevention in Atrial Fibrillation Study Group Investigators
    N Engl J Med; 1990 Mar; 322(12):863-8. PubMed ID: 2407959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term antithrombotic treatment for atrial fibrillation.
    Nademanee K; Kosar EM
    Am J Cardiol; 1998 Oct; 82(8A):37N-42N. PubMed ID: 9809899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation.
    ; Singer DE; Hughes RA; Gress DR; Sheehan MA; Oertel LB; Maraventano SW; Blewett DR; Rosner B; Kistler JP
    N Engl J Med; 1990 Nov; 323(22):1505-11. PubMed ID: 2233931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Warfarin or aspirin for non-rheumatic atrial fibrillation?
    Drug Ther Bull; 1994 Aug; 32(8):57-60. PubMed ID: 7635036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atrial fibrillation and anticoagulation.
    Marcus RR; Atwood JE
    Adv Intern Med; 1999; 44():239-65. PubMed ID: 9929711
    [No Abstract]   [Full Text] [Related]  

  • 20. [Stroke and other thromboembolic complications of atrial fibrillation. Part VI. Choice of optimal approach and drugs for prevention of stroke].
    Preobrazhenskiĭ DV; Sidorenko BA; Kiktëv VG; Batyraliev TA; Pershukov IV
    Kardiologiia; 2005; 45(1):84-93. PubMed ID: 15699946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.